Tela Bio Stock Analysis

TELA Stock  USD 2.35  0.08  3.29%   
Tela Bio is undervalued with Real Value of 4.04 and Target Price of 9.5. The main objective of Tela Bio stock analysis is to determine its intrinsic value, which is an estimate of what Tela Bio is worth, separate from its market price. There are two main types of Tela Bio's stock analysis: fundamental analysis and technical analysis.
The Tela Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Tela Bio's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

Tela Stock Analysis Notes

About 73.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.69. Tela Bio had not issued any dividends in recent years. TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients anatomy. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Tela Bio operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 123 people. To find out more about Tela Bio contact the company at 484 320 2930 or learn more at https://www.telabio.com.

Tela Bio Quarterly Total Revenue

18.96 Million

Tela Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Tela Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Tela Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Tela Bio generated a negative expected return over the last 90 days
Tela Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 58.45 M. Net Loss for the year was (46.66 M) with profit before overhead, payroll, taxes, and interest of 47.27 M.
Tela Bio currently holds about 27.73 M in cash with (40.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9.
Roughly 73.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: TELA Bio to Release Earnings on Thursday - Defense World

Tela Bio Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Tela Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
19th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Tela Largest EPS Surprises

Earnings surprises can significantly impact Tela Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-03-24
2020-12-31-0.49-0.54-0.0510 
2020-08-12
2020-06-30-0.59-0.530.0610 
2023-08-09
2023-06-30-0.53-0.460.0713 
View All Earnings Estimates

Tela Bio Environmental, Social, and Governance (ESG) Scores

Tela Bio's ESG score is a quantitative measure that evaluates Tela Bio's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Tela Bio's operations that may have significant financial implications and affect Tela Bio's stock price as well as guide investors towards more socially responsible investments.

Tela Stock Institutional Investors

Shares
Citigroup Inc2024-12-31
750 K
Sio Capital Management, Llc2024-12-31
630 K
Blackrock Inc2024-12-31
427.5 K
Renaissance Technologies Corp2024-12-31
425.1 K
Mink Brook Asset Management Llc2024-12-31
357.1 K
Geode Capital Management, Llc2024-12-31
311.4 K
Archon Capital Management Llc2024-12-31
150 K
Gsa Capital Partners Llp2024-12-31
135.8 K
Jpmorgan Chase & Co2024-12-31
133.7 K
Essex Woodlands Health Ventures2024-12-31
4.1 M
Nantahala Capital Management, Llc2024-12-31
3.7 M
Note, although Tela Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tela Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.71 M.

Tela Profitablity

The company has Profit Margin (PM) of (0.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.49.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.55)(0.58)
Return On Capital Employed(0.65)(0.68)
Return On Assets(0.54)(0.57)
Return On Equity(2.84)(2.70)

Management Efficiency

Tela Bio has return on total asset (ROA) of (0.4064) % which means that it has lost $0.4064 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4204) %, meaning that it created substantial loss on money invested by shareholders. Tela Bio's management efficiency ratios could be used to measure how well Tela Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of March 19, 2025, Return On Tangible Assets is expected to decline to -0.58. In addition to that, Return On Capital Employed is expected to decline to -0.68. At present, Tela Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 250.4 K, whereas Total Assets are forecasted to decline to about 63.7 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.74  0.78 
Tangible Book Value Per Share 0.66  0.69 
Enterprise Value Over EBITDA(3.23)(3.39)
Price Book Value Ratio 7.22  4.30 
Enterprise Value Multiple(3.23)(3.39)
Price Fair Value 7.22  4.30 
Enterprise Value131.2 M104.1 M
The decision-making processes within Tela Bio are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
(0.49)
Profit Margin
(0.60)
Beta
1.1
Return On Assets
(0.41)
Return On Equity
(3.42)

Technical Drivers

As of the 19th of March, Tela Bio has the Risk Adjusted Performance of (0.10), coefficient of variation of (810.82), and Variance of 6.78. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tela Bio, as well as the relationship between them.

Tela Bio Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tela Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tela Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tela Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tela Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tela Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tela Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Megan Smeykal over two weeks ago
Disposition of 423 shares by Megan Smeykal of Tela Bio at 2.72 subject to Rule 16b-3
 
Megan Smeykal over three weeks ago
Disposition of 5 shares by Megan Smeykal of Tela Bio at 2.65 subject to Rule 16b-3
 
Megan Smeykal over three weeks ago
Disposition of 423 shares by Megan Smeykal of Tela Bio at 2.72 subject to Rule 16b-3
 
Megan Smeykal over three weeks ago
Acquisition by Megan Smeykal of 9400 shares of Tela Bio subject to Rule 16b-3
 
Blizard Jeffrey over three months ago
Acquisition by Blizard Jeffrey of 6375 shares of Tela Bio subject to Rule 16b-3
 
Peter Murphy over three months ago
Acquisition by Peter Murphy of 19300 shares of Tela Bio at 7.07 subject to Rule 16b-3
 
Gregory Firestone over six months ago
Disposition of 1093 shares by Gregory Firestone of Tela Bio at 4.25 subject to Rule 16b-3
 
Antony Koblish over six months ago
Acquisition by Antony Koblish of 113200 shares of Tela Bio at 7.07 subject to Rule 16b-3
 
Orbimed Advisors Llc over six months ago
Disposition of 36600 shares by Orbimed Advisors Llc of Tela Bio at 4.54 subject to Rule 16b-3
 
Orbimed Advisors Llc over six months ago
Disposition of 36600 shares by Orbimed Advisors Llc of Tela Bio at 4.54 subject to Rule 16b-3
 
Orbimed Advisors Llc over six months ago
Disposition of 13700 shares by Orbimed Advisors Llc of Tela Bio at 4.68 subject to Rule 16b-3
 
Orbimed Advisors Llc over six months ago
Disposition of 378000 shares by Orbimed Advisors Llc of Tela Bio at 4.74 subject to Rule 16b-3

Tela Bio Outstanding Bonds

Tela Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tela Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tela bonds can be classified according to their maturity, which is the date when Tela Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Tela Bio Predictive Daily Indicators

Tela Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tela Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tela Bio Corporate Filings

F4
25th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
21st of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
14th of February 2025
Other Reports
ViewVerify
13th of February 2025
Other Reports
ViewVerify
12th of February 2025
Other Reports
ViewVerify
31st of January 2025
Other Reports
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
8th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify

Tela Bio Forecast Models

Tela Bio's time-series forecasting models are one of many Tela Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tela Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tela Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tela Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tela shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tela Bio. By using and applying Tela Stock analysis, traders can create a robust methodology for identifying Tela entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.72)(0.75)
Operating Profit Margin(0.68)(0.71)
Net Loss(0.72)(0.75)
Gross Profit Margin 0.62  0.47 

Current Tela Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tela analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tela analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.5Strong Buy4Odds
Tela Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Tela analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tela stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tela Bio, talking to its executives and customers, or listening to Tela conference calls.
Tela Analyst Advice Details

Tela Stock Analysis Indicators

Tela Bio stock analysis indicators help investors evaluate how Tela Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tela Bio shares will generate the highest return on investment. By understating and applying Tela Bio stock analysis, traders can identify Tela Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow42 M
Long Term Debt40.5 M
Common Stock Shares Outstanding22.9 M
Total Stockholder Equity18.9 M
Property Plant And Equipment Net3.9 M
Cash And Short Term Investments46.7 M
Cash46.7 M
Accounts Payable1.7 M
Net Debt-5.6 M
50 Day M A2.614
Total Current Liabilities17 M
Other Operating Expenses102.5 M
Non Current Assets Total6.3 M
Non Currrent Assets Other265 K
Stock Based CompensationM

Complementary Tools for Tela Stock analysis

When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges